株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染症治療薬の世界市場 (2019-2029年):抗ウイルス薬・抗菌薬・抗真菌薬

Anti-infective Agents Market Forecast 2019-2029: Anti-viral, Anti-bacterial, Anti-fungal, Hepatitis, HIV, Pneumonia, Aspergillosis, MRSA, Dermatophytosis, Tuberculosis, Respiratory Virus, Sepsis, Hospital Pharmacies, Retail Pharmacies, Online Sales

発行 Visiongain Ltd 商品コード 915071
出版日 ページ情報 英文 154 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=143.96円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
感染症治療薬の世界市場 (2019-2029年):抗ウイルス薬・抗菌薬・抗真菌薬 Anti-infective Agents Market Forecast 2019-2029: Anti-viral, Anti-bacterial, Anti-fungal, Hepatitis, HIV, Pneumonia, Aspergillosis, MRSA, Dermatophytosis, Tuberculosis, Respiratory Virus, Sepsis, Hospital Pharmacies, Retail Pharmacies, Online Sales
出版日: 2019年09月06日 ページ情報: 英文 154 Pages
概要

2018年における世界の感染症治療薬の市場は1090億ドルと推計されており、予測期間中は4.2%のCAGR (年間複合成長率) で成長すると予測されています。

当レポートでは、世界の感染症治療薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、適応症・タイプ・流通経路・地域/主要国別の動向と市場規模の推移と予測、薬剤開発パイプラインの動向、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 イントロダクション:感染症治療薬

  • 感染症治療薬とは
  • 感染症治療薬の特徴
  • データ・統計
  • 一般的な感染症
  • 感染症治療薬のタイプ
    • 抗菌薬
    • 抗真菌薬
    • 抗ウイルス薬

第3章 世界の感染症治療薬市場の分析・予測

  • 市場概要
  • 世界市場
  • 売上予測
  • 市場シェアの推移・予測:地域別

第4章 定性分析・予測

  • 市場成長推進因子
  • 市場成長抑制因子

第5章 感染症治療薬市場の分析・予測:適応症別

  • 市場概要
  • 市場予測
    • 肝炎
    • HIV
    • 肺炎
    • アスペルギルス症
    • MRSA
    • 皮膚糸状菌症
    • 結核
    • 呼吸器ウイルス
    • 敗血症

第6章 感染症治療薬市場の分析・予測:タイプ別

  • 市場概要
  • 市場予測
  • 抗ウイルス薬
  • 抗菌薬
    • βラクタム系
    • キノロン系
    • マクロライド系
    • テトラサイクリン系
    • アミノグリコシド系
  • 抗真菌薬
    • アゾール系
    • エキノキャンディン系
    • ポリエン系

第7章 感染症治療薬市場の分析・予測:流通経路別

  • 市場概要
  • 市場予測
    • 院内薬局
    • 小売薬局
    • オンライン販売

第8章 パイプライン分析・予測

  • 抗菌薬
  • 抗真菌薬
  • 抗ウイルス薬

第9章 主要国市場の分析・予測

  • 世界の感染症治療薬市場:地域別予測
  • 地域シェアの推移・予測
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 定性分析・予測

  • SWOT分析
  • ファイブフォース分析

第11章 企業プロファイル

  • Pfizer
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • GlaxoSmithKline Inc
  • Abbott Laboratories

第12章 総論

図表

List of Table

  • Table 3.1 Global Anti-infective agents market Forecast Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 5.1 Global Anti-infective Agents Market Forecast by Indication: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 5.2 Global Hepatitis Virus Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.3 Global HIV Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.4 Global Pneumonia Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.5 Global Aspergillosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.6 Global MRSA Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.7 Global Dermatophytosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.8 Global Tuberculosis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.9 Global Respiratory Virus Infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 5.10 Global Sepsis Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.1 Global Anti-infective Agents Market Forecast by Type: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 6.2 Global Antiviral Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.3 Global Antibacterial infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.4 Global B-lactams Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.5 Global Quinolones Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.6 Global Macrolides Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.7 Global Tetracycline Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.8 Global Aminoglycoside Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.9 Global Antifungal infection Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.10 Global Azoles Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.11 Global Echinocandins Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 6.12 Global Polyenes Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 7.1 Global Anti-infective agents market Forecast by Distribution Channel: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 7.2 Global Hospital Pharmacies Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 7.3 Global Retail Pharmacies Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 7.4 Global Online Sales Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
  • Table 9.1 World Anti-infective Agents Market by Region: Revenue ($bn) and Market Share (%) 2018 and 2029
  • Table 9.2 Global Anti-infective Agents Market Forecast by Region: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.3 North America Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.4 North America Anti-infective Agents Market by Region Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.5 US Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.6 Canada Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.7 Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.8 Europe Anti-infective Agents Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.9 Germany Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.10 UK Anti-infective agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.11 French Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.12 Rest of Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.13 Asia-Pacific Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
  • Table 9.14 Asia-Pacific Anti-infective Agents Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.15 Japanese Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.16 Chinese Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.17 Indian Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.18 Rest of APAC Anti-infective agents market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.19 Latin American Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 9.20 MEA Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Table 11.1 Overview: Pfizer
  • Table 11.2 Overview: Bristol-Myers Squibb Company
  • Table 11.3 Overview: Merck & Co., Inc
  • Table 11.4 Overview: Novartis
  • Table 11.5 Overview: Sanofi S.A.
  • Table 11.6 GSK Operating Segments
  • Table 11.7 GSK: Revenue ($m), R&D ($m), 2016-2018
  • Table 11.8 Abbott: Key Facts, 2017
  • Table 11.9 Abbott: Net Sales ($bn) and Revenue Shares (%) by Business Segment, 2017

List of Figure

  • Figure 1.1 Global Anti-infective agents market Segmentation Overview, 2018
  • Figure 3.1 Global Anti-infective agents market Forecast Revenue ($bn), AGR (%) 2019-2029
  • Figure 3.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018-2029
  • Figure 4.1 Anti-infective agents market: Drivers 2019-2029
  • Figure 4.2 Anti-infective agents market: Restraints 2019-2029
  • Figure 5.1 Global Anti-infective Agents by Indication: Market Share Forecast (%) 2018-2029
  • Figure 5.2 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2018
  • Figure 5.3 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2019
  • Figure 5.4 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2024
  • Figure 5.5 Global Anti-infective Agents Market Forecast by Indication: Market Shares (%), 2029
  • Figure 5.6 Global Hepatitis Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 5.7 Global HIV Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.8 Global Pneumonia Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.9 Global Aspergillosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.10 Global MRSA Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.11 Global Dermatophytosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.12 Global Tuberculosis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.13 Global Respiratory Virus Infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 5.14 Global Sepsis Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.1 Global Anti-infective agents market Forecast by Type Market Share (%) 2019-2029
  • Figure 6.2 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2018
  • Figure 6.3 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2024
  • Figure 6.4 Global Anti-infective Agents Market Forecast by Type: Market Shares (%), 2029
  • Figure 6.5 Global Antiviral Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.6 Global Antibacterial infection Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.7 Global B-Lactams Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.8 Global Quinolones Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.9 Global Macrolides Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.10 Global Tetracycline Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.11 Global Aminoglycoside Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.12 Global Antifungal infection Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
  • Figure 6.13 Global Azoles Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.14 Global Echinocandins Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 6.15 Global Polyenes Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 7.1 Global Anti-infective Agents by Distribution Channel Market Share (%) 2018-2029
  • Figure 7.2 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2018
  • Figure 7.3 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2024
  • Figure 7.4 Global Anti-infective agents by Distribution Channel: Market Shares (%), 2029
  • Figure 7.5 Global Hospital Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 7.6 Global Retail Pharmacies Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 7.7 Global Online Sales Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.1 Global Anti-infective Agents Market by Region: Revenues (%), 2018
  • Figure 9.2 Global Anti-infective Agents Market by Region: Revenues (%), 2024
  • Figure 9.3 Global Anti-infective Agents Market by Region: Revenues (%), 2029
  • Figure 9.4 North America Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.5 North America Anti-infective Agents Market by Region Forecast: Market Share 2018-2029
  • Figure 9.6 US Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.7 Canada Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.8 Europe Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.9 Europe Anti-infective Agents Market by Country: Revenue (%), 2018-2029
  • Figure 9.10 Germany Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.11 UK Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.12 French Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.13 Rest of Europe Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
  • Figure 9.14 Rest of Europe Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.15 Asia-Pacific Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.16 Asia-Pacific Anti-infective Agents Market by Country: Revenue (%), 2018-2029
  • Figure 9.17 Japanese Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.18 Chinese Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.19 Indian Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.20 Rest of APAC Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.21 Latin American Anti-infective Agents Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 9.22 MEA Anti-infective agents market Forecast: Revenue ($bn) and AGR (%), 2019-2029
  • Figure 10.1 SWOT Analysis of the Global Anti-infective Agents Market, 2019-2029
  • Figure 11.1 Pfizer: Financial Overview: 2016-2018
  • Figure 11.2 Bristol-Myers Squibb Company: Financial Overview 2016- 2018
  • Figure 11.3 Merck & Co., Inc: Financial Overview 2016-2018
  • Figure 11.4 Novartis: Financial Overview 2016-2018
  • Figure 11.5 Sanofi S.A.: Financial Overview 2016-2018
  • Figure 12.1 Global Anti-infective Agents Market Forecast: Revenue ($bn), AGR (%) 2019-2029
  • Figure 12.2 Global Anti-infective Agents Market Forecast Share (%) by Region 2018, 2024 & 2029

Companies Listed

  • Abbott Laboratories
  • Allergan
  • Amplyx Pharmaceuticals
  • Arno Therapeutics
  • AureoGen Biosciences
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Centers for Disease Control (CDC)
  • Cidara Therapeutics
  • Committee for Medicinal Products for Human Use (CHMP)
  • European Commission (EC)
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA)
  • GlaxoSmithKline (GSK)
  • InnoPharma
  • Merck & Co., Inc.
  • Mirati Therapeutics
  • Novartis AG
  • Pfizer
  • Sanofi SA
  • Roche
  • Tokuyama Corporation
  • Vical
  • World Health Organization (WHO)
目次
Product Code: PHA0442

The global anti-infective agents market is estimated to have reached $109bn in 2018 and is expected to grow at a CAGR of 4.2% during the forecast period. In 2018, the hospital pharmacy segment dominated the distribution channel of the anti-infective agents market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 127 charts - all unavailable elsewhere.

The 154-page report provides clear detailed insight into the anti-infective agents market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Anti-infective Agents Market forecasts from 2019-2029
  • Global Anti-infective Agents Market forecasts from 2019-2029 by Type :
  • Antiviral infections
  • Antibacterial infections : B-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside
  • Antifungal infections : Azoles, Echinocandins, Polyenes
  • Global Anti-infective Agents Market forecasts from 2019-2029 by Indication :
  • Hepatitis Virus Infection
  • HIV Infection
  • Pneumonia
  • Aspergillosis
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Dermatophytosis
  • Tuberculosis
  • Respiratory Virus Infection
  • Sepsis
  • Global Anti-infective Agents Market forecasts from 2019-2029 by Distribution Channel :
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Global Anti-infective Agents Market forecasts from 2019-2029 by regional and national market :
  • North America (US, Canada)
  • Europe (Germany, UK, France, Rest of Europe)
  • Asia Pacific (Japan, China, India, Rest of APAC)
  • RoW (Latin America, Middle East and Africa)

image1

  • Profiles of the selected leading companies:
  • Abbott Laboratories
  • Bristol-Myers Squibb
  • GlaxoSmithKline (GSK)
  • Merck & Co.
  • Novartis AG
  • Sanofi SA
  • Pfizer
  • Anti-infective agents R&D Pipeline
  • Key Questions Answered by this Report:
  • How is the Anti-infective Agents market evolving?
  • What is driving and restraining the Anti-infective Agents market dynamics?
  • How will each of the submarkets grow over the forecast period and how much revenue will these submarkets account for in 2029?
  • How will the market shares for each of the Anti-infective Agents submarkets develop from 2019 to 2029?
  • What will be the main driver for the overall market from 2019-2029?
  • How will political and regulatory factors influence the regional markets and submarkets?
  • How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry sector evolve during the period between 2019 and 2029?

Visiongain's study is intended for anyone requiring commercial analyses for the global anti-infective agents Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Anti-infective agents market Overview
  • 1.2 Global Anti-infective agents market Segmentation
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Why You Should Read This Report
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Who is This Report For?
  • 1.8 Methodology
  • 1.9 Frequently Asked Questions (FAQ)
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to Anti-infectives

  • 2.1 What Are Anti-infectives?
  • 2.2 Characteristics of Anti-infective agents
  • 2.3 Rare Disease Facts and Statistics
  • 2.4 Common Infectious Diseases Worldwide
  • 2.5 Types of Anti-infectives
    • 2.5.1 Anti-bacterial Drugs
    • 2.5.2 Anti-fungal drugs
    • 2.5.3 Anti-viral drugs

3. Anti-infectives: World Market 2019-2029

  • 3.1 Anti-infective agents market Overview, 2018
  • 3.2 The World Anti-infective Agents market
  • 3.3 World Anti-infective Agents market: Sales Forecast 2019-2029
  • 3.4 Changing Market Shares by Region 2018-2029

4. Anti-infectives: Qualitative Analysis 2019-2029

  • 4.1 Anti-infective Agents Market: Drivers 2019-2029
    • 4.1.1 Increase in Prevalence of Infectious Diseases
    • 4.1.2 High Investment in Anti-infective agents R&D
    • 4.1.3 Growing Support of Government
  • 4.2 Anti-infective agents market Restraints: 2019-2029
    • 4.2.1 Challenges in Research and Development
    • 4.2.2 Stringent Government Regulations

5. Anti-infective Agents Market by Indication, 2019-2029

  • 5.1 Market Overview
  • 5.2 Market Forecast 2019-2029
    • 5.2.1 Hepatitis Virus Infection: Market Forecast, 2019-2029
    • 5.2.2 HIV Infection: Market Forecast, 2019-2029
    • 5.2.3 Pneumonia: Market Forecast, 2019-2029
    • 5.2.4 Aspergillosis: Market Forecast, 2019-2029
    • 5.2.5 Methicillin-resistant Staphylococcus Aureus (MRSA): Market Forecast, 2019-2029
    • 5.2.6 Dermatophytosis: Market Forecast, 2019-2029
    • 5.2.7 Tuberculosis: Market Forecast, 2019-2029
    • 5.2.8 Respiratory Virus Infection: Market Forecast, 2019-2029
    • 5.2.9 Sepsis: Market Forecast, 2019-2029

6. Anti-infective Agents Market by Type, 2019-2029

  • 6.1 Market Overview
  • 6.2 Market Forecast 2019-2029
  • 6.3 Antiviral Infections Market
  • 6.4 Antibacterial Infection Market
    • 6.4.1 B-Lactams Market
    • 6.4.2 Quinolones Market
    • 6.4.3 Macrolides Market
    • 6.4.4 Tetracycline Market
    • 6.4.5 Aminoglycoside Market
  • 6.5 Antifungal infection Market
    • 6.5.1 Azoles Market
    • 6.5.2 Echinocandins Market
    • 6.5.3 Polyenes Market

7. Anti-infective Agents Market by Distribution Channel 2019-2029

  • 7.1 Market Overview
  • 7.2 Market Forecast 2019-2029
  • 7.3 Hospital Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Online Sales

8. Anti-infective Agents market - Pipeline Analysis 2019-2029

  • 8.1 Antibacterials in Development
  • 8.2 Antifungals in Development
  • 8.3 Antivirals in development

9. Leading National Markets 2019-2029

  • 9.1 Geographical Breakdown of the World Anti-infective Agents market
  • 9.2 Global Anti-infective Agents market: Regional Forecast 2019-2029
  • 9.3 How Will Regional Market Shares Change to 2029?
  • 9.4 North America Anti-infective Agents market, 2019-2029
    • 9.4.1 US Anti-infective Agents Market Forecast 2019-2029
    • 9.4.2 Canada Anti-infective Agents Market Forecast 2019-2029
  • 9.5 Europe Anti-infective Agents market, 2019-2029
    • 9.5.1 Europe Anti-infective agents market Forecast 2019-2029
    • 9.5.2 Germany Anti-infective Agents Market Forecast 2019-2029
    • 9.5.3 UK Anti-infective Agents Market Forecast 2019-2029
    • 9.5.4 French Anti-infective Agents Market Forecast 2019-2029
    • 9.5.5 Rest of Europe Anti-infective Agents Market Forecast 2019-2029
  • 9.6 Asia-Pacific Anti-infective Agents Market 2019-2029
    • 9.6.1 Japanese Anti-infective Agents Market Forecast 2019-2029
    • 9.6.2 Chinese Anti-infective Agents Market 2019-2029
    • 9.6.3 Indian Anti-infective Agents Market 2019-2029
    • 9.6.4 Rest of APAC Anti-infective Agents Market Forecast 2019-2029
  • 9.7 RoW Anti-infective Agents Market 2019-2029
    • 9.7.1 Latin American Anti-infective Agents Market Forecast 2019-2029
    • 9.7.2 MEA Anti-infective Agents Market 2019-2029

10. Anti-infective Agents Market: Qualitative Analysis, 2019-2029

  • 10.1 Anti-infective Agents Market: SWOT Analysis, 2019-2029
    • 10.1.1 Strengths
      • 10.1.1.1 Promising Anti-infective Drugs R&D Pipeline
      • 10.1.1.2 Increase in incidence of infectious diseases and healthcare awareness
    • 10.1.2 Weaknesses
    • 10.1.3 High Research and Development Cost
    • 10.1.4 Opportunities
    • 10.1.5 Demand from Emerging Market Continues
    • 10.1.6 Increase in Government Support
    • 10.1.7 Threats
    • 10.1.8 Uncertainty of R&D Results
    • 10.1.9 Barriers to Market Entry
  • 10.2 Anti-infective Agents Market: Porters Five Forces Analysis, 2019-2029
    • 10.2.1 Bargaining Power of Supplier: Moderate
    • 10.2.2 Bargaining Power of Buyer: Medium
    • 10.2.3 Competitive Rivalry: Medium
    • 10.2.4 The Threat of New Entrants: Low
    • 10.2.5 Threat of Substitutes: Medium

11. Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Financial Overview
    • 11.1.2 Recent Developments
  • 11.2 Bristol-Myers Squibb Company
    • 11.2.1 Financial Overview
    • 11.2.2 Recent Developments
  • 11.3 Merck & Co., Inc.
    • 11.3.1 Financial Overview
    • 11.3.2 Recent Developments
  • 11.4 Novartis AG
    • 11.4.1 Financial Overview
  • 11.5 Sanofi S.A.
    • 11.5.1 Financial Overview
    • 11.5.2 Recent Developments
  • 11.6 GlaxoSmithKline Inc
    • 11.6.1 Company Overview
    • 11.6.2 Operating Segments
    • 11.6.3 Financial Highlights
    • 11.6.4 Recent Developments
  • 11.7 Abbott Laboratories
    • 11.7.1 Sales and Recent Performance Analysis

12. Conclusion

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form
Back to Top